Zebing Liu

5PUBLICATIONS

24CO-AUTHORS

Molecular targetsSolid tumoursPredictive and prognostic markersHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 22, 2026

Combined inhibition of BETs and HDACs as a potential epigenetics-based therapy for malignant rhabdoid tumor.

|Aug 09, 2024

HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor.

Tom Zhang, Christopher A Febres-Aldana, Zebing Liu

|Dec 20, 2023

Rare myxoid pleomorphic liposarcoma: a case report and literature review.

Yanying Shen, Ling Zhao, Anqi Li

|Sep 26, 2021

CHPF promotes gastric cancer tumorigenesis through the activation of E2F1.

Xiaolin Lin, Ting Han, Qing Xia

|Jun 08, 2018

Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma.

Zebing Liu, Ying Cai, Yu Yang

Pageof 1

Frequent Collaborators

Xiaolin Lin

Liwei Wang

Xiuying Xiao

Lisha Wang

Tom Zhang

Christopher A Febres-Aldana

Jenna-Marie Dix

Ryan Cheng

Raymond G Dematteo

Allan J W Lui

Frequent Collaborators

Xiaolin Lin

Liwei Wang

Xiuying Xiao

Lisha Wang